Altasciences Wins 2025 CDMO Leadership Award for Small Molecule Dosage Form Excellence in North America
Altasciences, a renowned leader in contract research and development, is proud to announce its recognition as the recipient of the 2025 CDMO Leadership Award in the Small Molecule Dosage Form – North America category. This prestigious accolade underscores Altasciences’ commitment to delivering innovative, high-quality solutions that accelerate drug development and bring life-changing therapies to patients faster.
A Legacy of Excellence in Drug Development
As a nine-time winner of the CRO Leadership Award, Altasciences has consistently demonstrated its expertise in supporting pharmaceutical and biotech innovators. The company’s CDMO (Contract Development and Manufacturing Organization) site plays a pivotal role in advancing drug development by offering end-to-end services, including formulation, manufacturing, and analytical testing. From early discovery to commercialization, Altasciences provides integrated solutions tailored to meet the unique needs of its clients.
The state-of-the-art FDA-inspected facility features cutting-edge infrastructure, including Class C cleanrooms, R&D and analytical laboratories, ICH stability chambers, and a cGMP-compliant warehouse. These resources ensure the highest standards of quality and compliance throughout the drug development lifecycle.
Unwavering Dedication to Innovation and Collaboration
“This award reflects the unwavering dedication and expertise of our CDMO team, as well as our tireless commitment to advancing drug development in collaboration with leading pharmaceutical and biotech innovators,” said Marie-Hélène Raigneau, Co-Chief Operating Officer at Altasciences. “We are grateful for the opportunity to work with distinguished sponsors from around the world, offering them integrated solutions that not only support groundbreaking therapeutic advances but also make a significant contribution to bringing these therapies to the people who need them more quickly.”
Altasciences’ success lies in its ability to deliver comprehensive, customized solutions that address the complex challenges of drug development. By leveraging its deep expertise and advanced capabilities, the company ensures seamless transitions from preclinical to clinical phases, enabling faster delivery of safe and effective therapeutics.
Recognizing Industry Leaders: The CDMO Leadership Awards
For 14 years, Outsourced Pharma’s CDMO Leadership Awards have celebrated the highest-performing contract development and manufacturing organizations. These awards are based on extensive industry research and feedback from sponsors, making them a trusted benchmark for excellence in the outsourcing community.
“We are excited to present our 2025 CDMO Leadership Awards winners to the outsourcing community and honored to provide drug sponsors with such a critical tool to select the most suitable partner to bring life-saving therapies to market,” said Louis Garguilo, Editor-in-Chief at Outsourced Pharma. “The new categories and improved evaluation methodology incorporated into this year’s evaluation provide an enhanced experience for drug sponsors using the resource, as well as a highly sought-after award for CDMOs.”
This year’s awards highlight Altasciences’ leadership in small molecule dosage form development, recognizing the company’s ability to deliver exceptional value to its clients and partners.
Comprehensive Expertise Across Dosage Forms
Altasciences’ CDMO facility boasts extensive experience in formulating, testing, and manufacturing nearly every pharmaceutical dosage form available on the market. These include:
- Tablets
- Liquid and powder-filled capsules
- Over-encapsulated capsules
- Nano-milled suspensions
- Creams, gels, and powders
- Terminally sterilized injectables
By supporting all phases of drug development—from early formulation to late-stage scale-up and commercial manufacturing—Altasciences ensures consistency, quality, and compliance at every step. The company’s in-house analytical testing and environmental monitoring capabilities further enhance batch consistency and reliability, providing clients with peace of mind throughout the development process.
Accelerating Drug Development Through Integrated Services
One of Altasciences’ key differentiators is its ability to integrate formulation, manufacturing, and analytical processes under one roof. This streamlined approach eliminates bottlenecks, reduces timelines, and enhances collaboration between teams. By leveraging its in-house expertise, Altasciences accelerates the transition from preclinical to clinical development, enabling faster delivery of therapies to patients.
The company’s commitment to innovation and efficiency has made it a trusted partner for pharmaceutical and biotech companies worldwide. Whether developing small molecules, biologics, or advanced drug delivery systems, Altasciences delivers tailored solutions that meet the evolving needs of its clients.
Driving the Future of Drug Development
The 2025 CDMO Leadership Award is a testament to Altasciences’ dedication to excellence and innovation in small molecule dosage form development. As the pharmaceutical industry continues to evolve, the demand for reliable, high-quality CDMO partners will only grow. Altasciences is well-positioned to meet this demand, offering cutting-edge solutions that address the complexities of modern drug development.
By combining advanced technology, expert knowledge, and a client-centric approach, Altasciences is driving the future of drug development. The company’s achievements not only benefit its clients but also contribute to improving patient outcomes and advancing global healthcare.
Why Choose Altasciences?
For pharmaceutical and biotech companies seeking a trusted partner to navigate the complexities of drug development, Altasciences stands out as a leader in the field. With its award-winning expertise, state-of-the-art facilities, and commitment to collaboration, Altasciences is dedicated to delivering solutions that accelerate timelines, reduce risks, and ensure the highest standards of quality.
To learn more about Altasciences’ CDMO services and how they can support your drug development journey, visit their website or contact their team of experts today. Together, let’s bring life-saving therapies to market faster and improve the lives of patients around the world.
